Search for company
Explore more than 1.3 million company profiles from emerging markets

Dongkook Pharmaceutical Co.,Ltd. (Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 61,300.00
Volume 87,643
Turnover 5,175,319,150
Index
Market Korea Stock Exchange
Ticker 86450
Market Cap Market Cap 545,079,600
52 Week High 61,300.00
52 Week Low 25,600.00
P/E 25.28
EPS 2424.87
Dividend Yield
Bookvalue 172,869,432
Enterprise Value 520,520,406
Quote updated on May 28, 2015
Note: data in KRW Thousands.
Financials
Select Items to chart them. 2014 Y
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets 239,600,261
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: Korea Information Service (KIS), EMIS Company Database.
Company Description

Sales increased over the year-earlier periods with rising price of main product Insadol and high awareness of oral cavity disease medicines.Stable profitability was maintained with steady sales cost ratio while most of material drugs are produced in its material synthesis plants.Pipeline is expanded into new business sectors including premature ejaculation medicine joint developed with CTC BIO. Growth trend will continue with rising demand for menopause medicine and skin ailment disease and launch of new…

More
Main Products

Prefilled syringe system

Contact Information

Headquarters
7, Teheran-ro 108-gil Gangnam-gu Seoul
Seoul; Seoul; Map
Postal Code: 135502
Tel: 02-2191-9800
Fax: 02-566-8542
Website: http://www.dkpharm.co.kr

Full name: Dongkook Pharmaceutical Co.,Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Incorporation Date: 15-Oct-68

Basic Information
Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()
Key Executives
President
More
Ownership Details
Kwon Gi Beom
20.2%
Other
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Competitors - Korea
KRW | USD | EUR
Analysis/Research

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

USE OF YOUR INFORMATION:
EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.